Abstract: 
Introduction
G-6-P D deficiency is most common disease causing enzyme defect in humans. 1 It is a X linked genetic disorder. Both the homozygotes and heterozygotes can be asymptomatic but the hemolysis is more severe in homozygotes. Acute hemolysis is caused by exposure to an oxidative stressor in the form of an infection, oxidative drug or fava beans, the treatment is geared toward avoidance of these and other stressors. Acute hemolysis is self-limited, but in rare instances it can be severe enough to warrant a blood transfusion. 
II. Case Report
A pre term neonate male aged 16 days, 2.3 kg was presented to department of pediatrics with complaint of fever for 4 days, swelling right knee with decreased movements for 2 days. Fever was insidious in onset and in the range of 102⁰ F -104⁰ F which got relieved on medication. The swelling in right knee was also insidious in onset and associated with restricted movement of right limb. There was no hstory of trauma or vaccination . X Ray knee joint showed joint effusion. USG was advised and USG showed inflammatory changes in knee joint. Patient was planned for arthrotomy of the joint. The child was diagnosed case of G-6-PD deficiency during antenatal period and mother had cholestatic jaundice of pregnancy. Child was born by normal vaginal delivery at POG of 35 weeks 4days with a birthweight of 2.18 kg. Patient had history of neonatal jaundice at the day 3 and received phototherapy. The maximum total serum bilirubin was 14 mg/dl. At the time of presentation to operation theatre, hemoglobin was 8.7g/dl, platelet count was 5.28lac /dl. Serum sodium and potassium were 135.3 and 5.11 mg/dl respectively. In family history, neonate had a 5 years old brother with similar h/o neonatal jaundice who had undergone exchange transfusion twice. The child also developed hearing loss for which he underwent cochlear implant at the age of 5 years.
Anaesthetic management should focus on avoiding the drugs implicated in haemolysis, and monitoring for and treating the haemolysis, should it occur. 3 The patient was induced with fentanyl 4μg and halothane, atracurium 0.5 mg/kg. Trachea was intubated with 3.5 mm ID uncuffed tracheal tube. Tube was fixed after confirmation of bilateral air entry. Intraoperative monitoring included electrocardiogram (ECG), oxygen saturation (SpO2), non invasive blood pressure (NIBP) and end tidal carbon dioxide (EtCO2). Anesthesia was maintained with halothane, O2/N2O mixture and intermittent boluses of atracurium. Blood transfusion was given with 15 ml of cross matched packed cell blood. Trachea was extubated after adequate reversal achieved .The child was watched postoperatively for any deterioration of vitals, urine output and any signs of hemolysis.
III. Discussion
G-6-PD is commonest enzyme deficiency worldwide. It is X linked enzymopathy. G-6-PD catalyzes first step of penthose phosphate metabolism which is exclusive source of NADPH (Nicotinamide adenine dinucleotide phosphate). 4 NADPH protects cells from oxidative damage. As erythrocytes donot generate NADPH from any other way so are more susceptible to destruction from oxidative stress. 5 It can present as anemia and neonatal jaundice. Jaundice is considered to be due to an imbalance between production and conjugation of bilirubin.The prevalence of neonatal hyperbilirubinemia is twice that of the general population 6 in males who carry the defective gene and in homozygous females. It rarely occurs in heterozygous females. 7, 8 Anaesthetic Management Of A Neonate With Glucose -6 -Phosphatase…. DOI: 10.9790/0853-1605050608 www.iosrjournals.org 7 | Page G-6-PD deficiency should be considered in neonates who develop hyperbilirubinemia within the first 24 hours of life, a history of jaundice in a sibling, bilirubin levels greater than the 95th percentile, and in asian males. 9, 10 In our patient there was a history of neonatal jaundice at the age of three days for which phototherapy was given to him. There was a similar history of neonatal jaundice in the elder sibling with a progressive sensorineural hearing loss leading to cochlear implant. The G-6-PD levels were done based on high suspicion and the levels were found to be low.
Our aim was to provide safe anesthesia as the anesthetic drugs, NSAIDS and some antibiotics can cause hemolytic anaemia. 11 The World Health Organization has classified the different G6PD variants according to the magnitude of the enzyme deficiency and severity of haemolysis. Class I variant have severe enzyme deficiency (less than 10% of normal) and have chronic anemia. Class II variants also have severe enzyme deficiency, but there is usually only intermittent hemolysis. Class III variant have moderate enzyme deficiency (10 to 60% of normal) with intermittent hemolysis, usually associated with infections or drugs. Class IV variants have no enzyme deficiency or hemolysis. Class V variants have increased increased enzyme activity. Class IV and V are of no clinical significance. So in accordance with the study by Altikatet al, 14 we administered the safe drugs during the induction and maintenance of anesthesia. The use of G-6-PD inhibitors may worsen the health status of the patient. Hence the diagnosis of G-6-PD deficiency in patients with high suspicion along with the avoidance of the harmful drugs is the key to safety.
IV. Conclusion
G-6-PD deficiency is a common but underdiagnosed enzymopathy. Any male child with neonatal jaundice who has early onset within 24 hours and very high levels of bilirubin should be screened for the G6PD deficiency. The avoidance of the unsafe drugs is the key to safety in these children.
